This one-day symposium is aimed at exploring the latest approaches in drug discovery and will review the hottest topics towards discovering the drugs of tomorrow. Bringing together a wide range of industrial speakers, the day will cover a broad range of approaches and new targets within drug discovery.
Topics will cover both small molecule drug discovery as well as looking at those approaches to larger molecules such as antibody drug conjugates and bicyclic peptides. The meeting will cover a range of topics, from exploring the ways artificial intelligence and computational chemistry can impact drug discovery, to new targets for research within deubiquintinating enzymes and immune-oncology.
|09.40||Introduction and welcome|
|09.50||Dr. Miles Congreve, Heptares
|10.25||Dr. Rebecca Paul, BenevolentAI
|11.30||Dr. Andrea Bortolato, Schrödinger|
|12.05||Mr. Will Farnaby, Biological Chemistry and Drug Discovery, University of Dundee
|13.40||Dr. David Hardick, Storm Therapeutics
|14.15||Dr. James Dale, Nanna Therapeutics
|15.20||Dr. Mike Bodkin, Evotec
|15.55||Dr. Gemma Mudd, Bicycle Therapeutics
|16.30||Networking and refreshments
Tel: +44 (0)20 7598 1561
Early bird fees before Thursday 9 May 2019
|£30||SCI Student Member|
|£60||SCI Subsidised Member|
Standard fees after Thursday 9 May 2019
|£40||SCI Student Member|
|£80||SCI Subsidised Member|
SCI Platinum Corporate Members receive 25% off the above rate
You must sign up for membership to join this event. FREE membership options available.
SCI Members attending this meeting are able to claim CPD points.